GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,031,000 | +3.4% | 156,600 | +15.8% | 0.02% | 0.0% |
| Q3 2016 | $5,832,000 | -0.6% | 135,220 | -0.1% | 0.02% | -4.8% |
| Q2 2016 | $5,866,000 | -39.2% | 135,359 | -43.1% | 0.02% | -40.0% |
| Q1 2016 | $9,643,000 | +8.6% | 237,800 | +8.0% | 0.04% | +9.4% |
| Q4 2015 | $8,881,000 | +133.4% | 220,100 | +121.9% | 0.03% | +128.6% |
| Q3 2015 | $3,805,000 | -42.7% | 99,200 | -37.8% | 0.01% | -39.1% |
| Q2 2015 | $6,643,000 | +20.5% | 159,500 | +32.7% | 0.02% | +21.1% |
| Q1 2015 | $5,515,000 | -57.9% | 120,158 | -60.7% | 0.02% | -58.7% |
| Q4 2014 | $13,114,000 | -6.3% | 305,600 | 0.0% | 0.05% | -9.8% |
| Q3 2014 | $14,001,000 | -14.3% | 305,600 | 0.0% | 0.05% | -15.0% |
| Q2 2014 | $16,345,000 | +0.8% | 305,600 | 0.0% | 0.06% | -4.8% |
| Q1 2014 | $16,217,000 | +15.4% | 305,600 | +16.2% | 0.06% | +12.5% |
| Q4 2013 | $14,047,000 | +6.4% | 263,100 | 0.0% | 0.06% | 0.0% |
| Q3 2013 | $13,200,000 | +0.4% | 263,100 | -0.0% | 0.06% | -8.2% |
| Q2 2013 | $13,149,000 | – | 263,136 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |